188 related articles for article (PubMed ID: 18690962)
1. Recombinant activated factor VII as a general haemostatic agent: evidence-based efficacy and safety.
Squizzato A; Ageno W
Curr Drug Saf; 2007 May; 2(2):155-61. PubMed ID: 18690962
[TBL] [Abstract][Full Text] [Related]
2. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
Stanworth SJ; Birchall J; Doree CJ; Hyde C
Cochrane Database Syst Rev; 2007 Apr; (2):CD005011. PubMed ID: 17443565
[TBL] [Abstract][Full Text] [Related]
3. Update on Novo Nordisk's clinical trial programme on NovoSeven.
Dejgaard A
Blood Coagul Fibrinolysis; 2003 Jun; 14 Suppl 1():S39-41. PubMed ID: 14567535
[TBL] [Abstract][Full Text] [Related]
4. Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Brenner B; Wiis J
Hematology; 2007 Feb; 12(1):55-62. PubMed ID: 17364994
[TBL] [Abstract][Full Text] [Related]
5. Haemostatic drug therapies for acute primary intracerebral haemorrhage.
You H; Al-Shahi R
Cochrane Database Syst Rev; 2006 Jul; (3):CD005951. PubMed ID: 16856109
[TBL] [Abstract][Full Text] [Related]
6. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
Lin Y; Stanworth S; Birchall J; Doree C; Hyde C
Cochrane Database Syst Rev; 2011 Feb; (2):CD005011. PubMed ID: 21328270
[TBL] [Abstract][Full Text] [Related]
7. To general haemostasis--the evidence-based route.
Erhardtsen E
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():47-52. PubMed ID: 12214148
[TBL] [Abstract][Full Text] [Related]
8. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
Simpson E; Lin Y; Stanworth S; Birchall J; Doree C; Hyde C
Cochrane Database Syst Rev; 2012 Mar; (3):CD005011. PubMed ID: 22419303
[TBL] [Abstract][Full Text] [Related]
9. Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.
Selin S; Tejani A
Issues Emerg Health Technol; 2006 Mar; (82):1-4. PubMed ID: 16602203
[TBL] [Abstract][Full Text] [Related]
10. Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage.
Al-Shahi Salman R
Cochrane Database Syst Rev; 2009 Oct; (4):CD005951. PubMed ID: 19821350
[TBL] [Abstract][Full Text] [Related]
11. Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients.
Guzzetta NA; Russell IA; Williams GD
Anesth Analg; 2012 Aug; 115(2):364-78. PubMed ID: 22652310
[TBL] [Abstract][Full Text] [Related]
12. Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications.
Yank V; Tuohy CV; Logan AC; Bravata DM; Staudenmayer K; Eisenhut R; Sundaram V; McMahon D; Olkin I; McDonald KM; Owens DK; Stafford RS
Ann Intern Med; 2011 Apr; 154(8):529-40. PubMed ID: 21502651
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.
Martinowitz U; Michaelson M;
J Thromb Haemost; 2005 Apr; 3(4):640-8. PubMed ID: 15842347
[TBL] [Abstract][Full Text] [Related]
14. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery.
Coppola A; Windyga J; Tufano A; Yeung C; Di Minno MN
Cochrane Database Syst Rev; 2015 Feb; (2):CD009961. PubMed ID: 25922858
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of eptacog alfa in nonhaemophiliac conditions.
Mallarkey G; Brighton T; Thomson A; Kaye K; Seale P; Gazarian M
Drugs; 2008; 68(12):1665-89. PubMed ID: 18681490
[TBL] [Abstract][Full Text] [Related]
16. Recombinant factor VIIa in the treatment of postoperative hemorrhage after cardiac surgery.
Raivio P; Suojaranta-Ylinen R; Kuitunen AH
Ann Thorac Surg; 2005 Jul; 80(1):66-71. PubMed ID: 15975342
[TBL] [Abstract][Full Text] [Related]
17. The potential use of recombinant activated factor VII in trauma and surgery.
Sapsford W
Scand J Surg; 2004; 93(1):17-23. PubMed ID: 15116814
[TBL] [Abstract][Full Text] [Related]
18. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
[TBL] [Abstract][Full Text] [Related]
19. Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review.
Grounds M
Blood Rev; 2003 Sep; 17 Suppl 1():S11-21. PubMed ID: 14697209
[TBL] [Abstract][Full Text] [Related]
20. General haemostatic agents--fact or fiction?
Hedner U
Pathophysiol Haemost Thromb; 2002; 32 Suppl 1():33-6. PubMed ID: 12214145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
